Monoclonal Antibody-based Therapies: a New Dawn in the Treatment of Acute Lymphoblastic Leukemia

Overview

Journal J Clin Oncol

Specialty Oncology

Date 2012 Aug 15

PMID 22891271

Citations 35

Authors

Hagop Kantarjian

Deborah Thomas

Alan S Wayne

Susan OBrien

Affiliations

Soon will be listed here.

Citing Articles

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Hayakawa F, Mori N, Imai K, Yokoyama Y, Katsuoka Y, Saito T Cancer Sci. 2024; 116(2):453-461.

PMID: 39572007 PMC: 11786320. DOI: 10.1111/cas.16405.

Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.

Kim D, Orr M, Kwong A, Deibler K, Munshi H, Bridges C ACS Med Chem Lett. 2023; 14(5):606-613.

PMID: 37197477 PMC: 10184151. DOI: 10.1021/acsmedchemlett.3c00029.

Clathrin light chain-conjugated drug delivery for cancer.

Jung S, Jiang L, Zhao J, Shultz L, Greiner D, Bae M Bioeng Transl Med. 2023; 8(1):e10273.

PMID: 36684105 PMC: 9842032. DOI: 10.1002/btm2.10273.

The cure of leukemia through the optimist's prism.

Kantarjian H, Jain N, Garcia-Manero G, Welch M, Ravandi F, Wierda W Cancer. 2021; 128(2):240-259.

PMID: 34614211 PMC: 8738114. DOI: 10.1002/cncr.33933.

Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.

Sachs K, Sarver A, Noble-Orcutt K, LaRue R, Antony M, Chang D Cancer Res. 2019; 80(3):458-470.

PMID: 31784425 PMC: 7002190. DOI: 10.1158/0008-5472.CAN-18-2932.

References

Zwaan C, Reinhardt D, Jurgens H, Huismans D, Hahlen K, Smith O . Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin. Leukemia. 2003; 17(2):468-70. DOI: 10.1038/sj.leu.2402749. View

Younes A, Kim S, Romaguera J, Copeland A, Farial S, Kwak L . Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma. J Clin Oncol. 2012; 30(22):2776-82. PMC: 5950497. DOI: 10.1200/JCO.2011.39.4403. View

Raponi S, De Propris M, Intoppa S, Milani M, Vitale A, Elia L . Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases. Leuk Lymphoma. 2011; 52(6):1098-107. DOI: 10.3109/10428194.2011.559668. View

Pui C, Evans W . Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006; 354(2):166-78. DOI: 10.1056/NEJMra052603. View

Wayne A, Shah N, Bhojwani D, Silverman L, Whitlock J, Stetler-Stevenson M . Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia. Blood. 2017; 130(14):1620-1627. PMC: 5630009. DOI: 10.1182/blood-2017-02-749101. View

Thorson J, Sievers E, Ahlert J, Shepard E, Whitwam R, Onwueme K . Understanding and exploiting nature's chemical arsenal: the past, present and future of calicheamicin research. Curr Pharm Des. 2000; 6(18):1841-79. DOI: 10.2174/1381612003398564. View

Bassan R, Rossi G, Pogliani E, Di Bona E, Angelucci E, Cavattoni I . Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. J Clin Oncol. 2010; 28(22):3644-52. DOI: 10.1200/JCO.2010.28.1287. View

Nicholas Haining W, Cardoso A, Keczkemethy H, Fleming M, Neuberg D, DeAngelo D . Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemia. Exp Hematol. 2005; 33(3):286-94. DOI: 10.1016/j.exphem.2004.12.001. View

Faderl S, OBrien S, Pui C, Stock W, Wetzler M, Hoelzer D . Adult acute lymphoblastic leukemia: concepts and strategies. Cancer. 2010; 116(5):1165-76. PMC: 5345568. DOI: 10.1002/cncr.24862. View

10.

Blanc V, Bousseau A, Caron A, Carrez C, Lutz R, Lambert J . SAR3419: an anti-CD19-Maytansinoid Immunoconjugate for the treatment of B-cell malignancies. Clin Cancer Res. 2011; 17(20):6448-58. DOI: 10.1158/1078-0432.CCR-11-0485. View

11.

Ricart A . Antibody-drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin. Clin Cancer Res. 2011; 17(20):6417-27. DOI: 10.1158/1078-0432.CCR-11-0486. View

12.

Bassan R, Hoelzer D . Modern therapy of acute lymphoblastic leukemia. J Clin Oncol. 2011; 29(5):532-43. DOI: 10.1200/JCO.2010.30.1382. View

13.

Polson A, Ho W, Ramakrishnan V . Investigational antibody-drug conjugates for hematological malignancies. Expert Opin Investig Drugs. 2010; 20(1):75-85. DOI: 10.1517/13543784.2011.539557. View

14.

Claviez A, Eckert C, Seeger K, Schrauder A, Schrappe M, Henze G . Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia. Haematologica. 2006; 91(2):272-3. View

15.

Wierda W, Kipps T, Mayer J, Stilgenbauer S, Williams C, Hellmann A . Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemia. J Clin Oncol. 2010; 28(10):1749-55. PMC: 4979101. DOI: 10.1200/JCO.2009.25.3187. View

16.

Thomas D, Faderl S, Cortes J, OBrien S, Giles F, Kornblau S . Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood. 2003; 103(12):4396-407. DOI: 10.1182/blood-2003-08-2958. View

17.

Elter T, Gercheva-Kyuchukova L, Pylylpenko H, Robak T, Jaksic B, Rekhtman G . Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial. Lancet Oncol. 2011; 12(13):1204-13. DOI: 10.1016/S1470-2045(11)70242-X. View

18.

Handgretinger R, Zugmaier G, Henze G, Kreyenberg H, Lang P, von Stackelberg A . Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia. Leukemia. 2010; 25(1):181-4. DOI: 10.1038/leu.2010.239. View

19.

Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E . Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol. 2009; 27(6):911-8. DOI: 10.1200/JCO.2008.18.6916. View

20.

Piccaluga P, Arpinati M, Candoni A, Laterza C, Paolini S, Gazzola A . Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia. Leuk Lymphoma. 2010; 52(2):325-7. DOI: 10.3109/10428194.2010.529206. View